Literature DB >> 12532393

Hydrolysis of oxaliplatin-evaluation of the acid dissociation constant for the oxalato monodentate complex.

Elin Jerremalm1, Staffan Eksborg, Hans Ehrsson.   

Abstract

Alkaline hydrolysis of the platinum anticancer drug oxaliplatin gives the oxalato monodentate complex and the dihydrated oxaliplatin complex in two consecutive steps. The acid dissociation constant for the oxalato monodentate intermediate was determined by a kinetic approach. The pK(a) value was estimated as 7.23. The monodentate intermediate is assumed to rapidly react with endogenous compounds, resulting in a continuous conversion of oxaliplatin via the monodentate form. Copyright 2003 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 92:436-438, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12532393     DOI: 10.1002/jps.10306

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: synthesis and comparison with carboplatin in normal and Pt-resistant cell lines.

Authors:  Jonathan F Arambula; Jonathan L Sessler; Mark E Fountain; Wen-hao Wei; Darren Magda; Zahid H Siddik
Journal:  Dalton Trans       Date:  2009-10-07       Impact factor: 4.390

2.  Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients.

Authors:  Yoichiro Yoshida; Seiichiro Hoshino; Naoya Aisu; Masayasu Naito; Syu Tanimura; Ai Mogi; Toshihiro Tanaka; Keiji Hirata; Kazuo Tamura; Yuichi Yamashita
Journal:  Int J Clin Oncol       Date:  2014-05-10       Impact factor: 3.402

3.  Oxaliplatin reacts with DMSO only in the presence of water.

Authors:  Hristo P Varbanov; Daniel Ortiz; Doris Höfer; Laure Menin; Mathea S Galanski; Bernhard K Keppler; Paul J Dyson
Journal:  Dalton Trans       Date:  2017-07-18       Impact factor: 4.569

4.  A Dogma in Doubt: Hydrolysis of Equatorial Ligands of PtIV Complexes under Physiological Conditions.

Authors:  Alexander Kastner; Isabella Poetsch; Josef Mayr; Jaroslav V Burda; Alexander Roller; Petra Heffeter; Bernhard K Keppler; Christian R Kowol
Journal:  Angew Chem Int Ed Engl       Date:  2019-04-25       Impact factor: 15.336

5.  A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.

Authors:  Yoichiro Yoshida; Keiji Hirata; Hiroshi Matsuoka; Shigeyoshi Iwamoto; Masahito Kotaka; Hideto Fujita; Naoya Aisu; Seiichiro Hoshino; Takeo Kosaka; Kotaro Maeda; Fumiaki Kiyomi; Yuichi Yamashita
Journal:  Drug Des Devel Ther       Date:  2015-11-11       Impact factor: 4.162

6.  Platinum-RNA modifications following drug treatment in S. cerevisiae identified by click chemistry and enzymatic mapping.

Authors:  Maire F Osborn; Jonathan D White; Michael M Haley; Victoria J DeRose
Journal:  ACS Chem Biol       Date:  2014-08-15       Impact factor: 5.100

7.  Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.

Authors:  Rudra Pangeni; Sang Won Choi; Ok-Cheol Jeon; Youngro Byun; Jin Woo Park
Journal:  Int J Nanomedicine       Date:  2016-11-30

8.  The hybrid models, containing hydrolytic and electron-driven processes, in theoretical study of oxaliplatin biotransformation.

Authors:  Janina Kuduk-Jaworska; Jerzy J Jański; Szczepan Roszak
Journal:  J Mol Model       Date:  2020-09-26       Impact factor: 1.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.